OverviewSuggest Edit

AstraZeneca is global innovation-driven biopharmaceutical company specialising in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in healthcare. AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of taking the treatment. They also focus on getting the best from every medicine they make by exploring all the ways it can be used or improved. Their business strategy sets out their path to success in delivering great medicines to patients through innovative science and global excellence in development and commercialisation. ... Show more
TypePublic
Founded1999
HQCambridge, GB
Websiteastrazeneca.com
Employee Ratings3.8

Latest Updates

Employees (est.) (Feb 2019)61,100
Job Openings2,598
Revenue (FY, 2017)£22.5 B(-2%)
Share Price (Feb 2019)$36.6 (-1%)

Key People/Management at AstraZeneca

Leif Johansson

Leif Johansson

Non-Executive Chairman of the Board
Pascal Soriot

Pascal Soriot

Executive Director and Chief Executive Officer
Marc Dunoyer

Marc Dunoyer

Executive Director and Chief Financial Officer
Graham Chipchase

Graham Chipchase

Senior Independent Non-Executive Director
Genevieve Berger

Genevieve Berger

Non-Executive Director
Philip Broadley

Philip Broadley

Non-Executive Director
Show more

AstraZeneca Office Locations

AstraZeneca has offices in Cambridge, Bristol, Buckinghamshire, Chester and in 166 other locations
Shanghai, CN
43/F CITIC Square, 1168 Nan Jing Xi Road
Wedel, DE
Wedel, Tinsdaler Weg 183
Hong Kong, HK
18/F, Shui On Centre, 6-8 Harbour Road, Wanchai
Bangalore, IN
Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road
Osaka, JP
Grand Front Osaka Tower B, 3-1, Ofuka-cho, Kita-ku
London, GB
15 Stanhope Gate
Show all (171)
Report incorrect company information

AstraZeneca Financials and Metrics

AstraZeneca Revenue

Embed Graph
View revenue for all periods
AstraZeneca's revenue was reported to be £22.46 b in FY, 2017
GBP

Revenue (FY, 2017)

22.5b

Gross profit (FY, 2017)

18.1b

Gross profit margin (FY, 2017), %

80.8%

Net income (FY, 2017)

2.9b

EBITDA (FY, 2017)

6.7b

EBIT (FY, 2017)

3.7b

Market capitalization (13-Feb-2019)

92.7b

Closing stock price (13-Feb-2019)

36.6

Cash (31-Dec-2017)

3.3b

EV

91.6b
AstraZeneca's current market capitalization is $92.7 b.
GBPFY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

5.4b5.2b5.5b11.4b12.1b11.4b11.1b10.5b11.5b14.0b13.5b14.8b19.8b16.9b19.6b19.1b23.0b22.5b

Revenue growth, %

1%(9%)(10%)

Cost of goods sold

2.2b2.0b2.2b3.7b3.7b3.1b2.8b2.5b2.8b3.1b2.7b3.2b4.1b3.5b4.3b3.6b4.1b4.3b

Gross profit

3.1b3.2b3.4b7.6b8.4b8.3b8.3b8.0b8.7b10.8b10.8b11.6b15.7b13.4b15.3b15.5b18.9b18.1b
GBPFY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

259.0m303.0m206.0m265.0m683.0m489.0m453.0m409.0m565.0m2.9b3.6b2.9b2.7b6.1b4.7b4.8b5.0b3.3b

Accounts Receivable

935.0m969.0m1.1b1.8b1.8b1.7b1.7b1.8b1.9b2.2b2.2b2.7b3.5b3.6b3.5b3.6b2.6b2.8b

Inventories

681.0m728.0m798.0m1.3b1.4b1.7b1.6b1.7b1.6b1.3b1.2b1.1b1.0b1.3b1.4b1.7b2.3b3.0b

Current Assets

3.0b2.9b2.7b6.1b7.0b6.8b7.6b7.2b7.7b8.0b8.7b8.6b10.0b13.2b12.2b12.3b13.0b12.9b
GBPFY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

655.0m736.0m715.0m704.0m1.7b2.1b1.8b1.7b2.1b2.8b3.1b2.8b3.8b1.7b913.3m2.2b3.4b2.9b

Cash From Operating Activities

1.1b1.2b1.2b1.9b2.8b2.6b3.5b2.4b3.2b3.9b3.9b3.8b5.5b4.9b5.2b4.0b4.1b3.6b

Dividends Paid

332.0m365.0m399.0m764.0m1.9b850.0m753.0m754.0m833.0m976.0m1.1b1.3b1.7b2.6b2.7b

Cash From Financing Activities

(39.0m)(32.0m)(96.0m)(112.0m)(267.0m)(665.0m)(794.0m)(811.0m)(740.0m)(2.7b)(2.7b)3.0b(4.0b)(2.0b)(2.0b)3.4b(1.3b)(2.9b)
GBPY, 2017

EV/EBITDA

13.7 x

EV/EBIT

24.9 x

EV/CFO

25.6 x

Revenue/Employee

367.7k

Debt/Equity

0.2 x

Financial Leverage

4.2 x
Show all financial metrics

AstraZeneca Operating Metrics

FY, 2013FY, 2014FY, 2015FY, 2016

Health Facilities Activated

250 403

Phase I Trials Products

33 24 44 41

Projects in R&D Pipeline

99 133 146 132

Young Health Programme Members

1.40 m1.60 m
Show all operating metrics

AstraZeneca Revenue Breakdown

Embed Graph

AstraZeneca revenue breakdown by business segment: 22.3% from Respiratory, Inflammation and Autoimmunity, 23.8% from Infection, Neuroscience and Gastrointestinal:, 15.9% from Oncology and 38.1% from Cardiovascular and Metabolic Diseases

Report incorrect company information

AstraZeneca Online and Social Media Presence

Embed Graph
Report incorrect company information

AstraZeneca News and Updates

Innovative Report on Diabetes Drug Therapy Market 2019: With Top Leading Players like Abbott Laboratories, Mannkind Corporation, Bristol Myers Squibb, Medtronic, AstraZeneca

Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is …

Stocks Radar: AstraZeneca Pharma, Chalet Hotels, Cummins India, Infosys, Sun Pharma

Here are the stocks moving the market this morning.

Volumes soar at Astrazeneca Pharma India Ltd counter

Astrazeneca Pharma India Ltd clocked volume of 12854 shares by 10:49 IST on BSE, a 13.2 times surge over two-week average daily volume of 974 shares

AstraZeneca Pharma sizzles after turnaround Q3 result

AstraZeneca Pharma India jumped 10.37% to Rs 1,772.70 at 09:25 IST on BSE after the company reported net profit of Rs 29.09 crore in Q3 December 2018 as against net loss of Rs 10.35 crore in Q3 December 2017.

Worldwide Vaccines Market 2019: Is Likely Expand Tremendous Growth In Near Future GlaxoSmithKline, Merck, Pfizer, Sanofi, AstraZeneca, Abbott, Pfizer, Mitsubishi Tanabe Pharma, LG Life Sciences

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. Poste…
Show more
Report incorrect company information

AstraZeneca Company Life and Culture

Report incorrect company information

AstraZeneca Frequently Asked Questions

  • When was AstraZeneca founded?

    AstraZeneca was founded in 1999.

  • Who are AstraZeneca key executives?

    AstraZeneca's key executives are Leif Johansson, Pascal Soriot and Marc Dunoyer.

  • How many employees does AstraZeneca have?

    AstraZeneca has 61,100 employees.

  • What is AstraZeneca revenue?

    Latest AstraZeneca annual revenue is £22.5 b.

  • What is AstraZeneca revenue per employee?

    Latest AstraZeneca revenue per employee is £367.7 k.

  • Who are AstraZeneca competitors?

    Competitors of AstraZeneca include Teva Pharmaceuticals, Bristol-Myers Squibb and Bayer.

  • Where are AstraZeneca offices?

    AstraZeneca has offices in Cambridge, Bristol, Buckinghamshire, Chester and in 166 other locations.

  • How many offices does AstraZeneca have?

    AstraZeneca has 171 offices.